Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.
Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor update to the page. No study data, eligibility criteria, or results appear to be affected.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedLocations were expanded to include site entries across multiple US states and Ontario. Older per-location entries (e.g., Alabama Locations, Ontario Locations) were removed, and a new Revision: v3.3.3 tag appears.SummaryDifference1%
- Check58 days agoChange DetectedPublications section now includes a note that PubMed-derived publications are automatically populated and may not all pertain to the study; the page revision has been updated to v3.3.2.SummaryDifference0.1%
- Check65 days agoChange DetectedRemoval of the government funding/operating status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check79 days agoChange DetectedThe screenshots show only minor formatting adjustments and small copy edits across the page. There are no changes to the core study data such as the title, identifiers, eligibility criteria, outcomes, enrollment, or locations.SummaryDifference0.2%
- Check108 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%
Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.